World Market for Diabetes Treatments, The now available at ReportsnReports

This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments
By: ReportsnReports.com
 
Dec. 6, 2010 - PRLog -- Dallas, TX: ReportsnReports announce World Market for Diabetes Treatments, The
http://www.reportsnreports.com/reports/36588-world-market-for-diabetes-treatments-the.html

Original Source : World Diabetes Market
http://www.reportsnreports.com/reports/36588-world-market-for-diabetes-treatments-the.html

Buy Now :  Market  Research
http://www.reportsnreports.com/

Browse complete Report at : World Market for Diabetes Treatments, The
http://www.reportsnreports.com/reports/36588-world-market-for-diabetes-treatments-the.html

This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments. The diabetes market is one of the fastest growing markets within the pharmaceutical sector, and is one of the few pharmaceutical sectors that are likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an aging worldwide population. The total market for diabetes treatments is divided into two major segments:
Insulin Markets in US, Europe, Japan, ROW
Oral Hypoglycemics in US, Europe, Japan, ROW
For each of these market segments the report provides market share and regional breakout (US, Europe, Asia, ROW). The report also discusses treatment for diabetes complications and natural and herbal treatments.
The report’s geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Trends covered in the report include:
New Products and the Development Pipeline (Afrezza, Bydureon, Syncria, AVE0010, Balaglitazone, Metgluna Otelixizumab and others)
Transplantation Research Efforts
Β-Cell Transplantation Research
Potential New Drug for Type 2 Diabetes
Insulin Pills
Three-month Insulin Shot
Outsourcing of Diabetes Projects
Reclassification of Cause of Death
Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets.

A market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included, including profiles of the following:

Amylin Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Eli Lilly & Co.
Merck
Metabolex, Inc.
Novo Nordisk A/S
Pfizer Inc.
Sanofi-Aventis Group
Takeda Pharmaceutical Company Limited
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information.

For the purpose of this study, Kalorama Information conducted interviews with more than 25 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2008, with forecast data provided for 2010 through 2015. Compound annual growth rates (CAGRs) are provided for 2008-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2015 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  Background
  Scope and Methodology
  Size and Growth of the Market
  Key Issues and Trends Affecting Market
  Leading Competitors

CHAPTER TWO: INTRODUCTION

  Background
  Therapeutic Practices
  France
  Germany
  Italy
  Japan
  Spain
  United Kingdom
  United States
  China
  India


CHAPTER THREE: CURRENT THERAPEUTICS FOR DIABETES

  Insulin
         Regular Insulin
         Long-Acting and Basal Insulin
         Rapidly Acting Insulin
         Combinations
         Insulin Pumps
         Insulin Pens
         Inhaled Insulin
         Other Treatments
  Oral Hypoglycemics
         Sulfonylureas Biguanides
         á-Glucosidase Inhibitors
         Thiazolidinediones
         Meglitinides
         D-Phenylalanine Derivatives
         GLP1 Agonists
         DPP-IV Inhibitor
  Current Therapeutics for Diabetic Complications
         Antihypertensive Therapy
         ACE Inhibitors
         á/â(Alpha/Beta)-Blockers
         Calcium Channel Blockers
         Diuretics
         Angiotensin II Receptor Antagonists
  Dyslipidemia Therapy
  HMG-CoA Reductase Inhibitors--Statins
  Bile Acid Sequestrants
  Fibric Acid Derivatives
  Niacin
  Cholesterol Absorption Inhibitors
  Atherosclerosis Therapy
  Arrhythmia Therapy
  Peripheral Vascular Disease Therapy

CHAPTER THREE: TOTAL MARKET REVENUES, FORECAST AND COMPETITIVE ANALYSIS

  Total Worldwide Diabetes Market Analysis by Geographic Segment
  Total Worldwide Diabetes Market Competitive Analysis
  Total Worldwide Diabetes Market by Segment
  Insulin
  Oral Hypoglycemics

CHAPTER FOUR: KEY ISSUES, TRENDS AND DEVELOPMENTS

ABBREVIATIONS

Browse all : Medical Devices
http://www.reportsnreports.com/market-research/medical-de...

Browse all : Kalorama Information
http://www.reportsnreports.com/publishers/kalorama-inform...

Browse all : Newly Published
http://www.reportsnreports.com/LatestReport.aspx

Related Reports :

The World Market for Diabetes Treatments
http://www.reportsnreports.com/reports/35297-the-world-market-for-diabetes-treatments.html

U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010
http://www.reportsnreports.com/reports/18577-us-market-for-diabetes-monitoring-treatment-and-drug-delivery-.html

Pipeline Insight: Asthma/COPD - Simplified treatments to split the market
http://www.reportsnreports.com/reports/7131-pipeline-insight-asthma-copd-simplified-treatments-to-split-th.html

U.S. Market for Chronic Venous Insufficiency Treatment 2009
http://www.reportsnreports.com/reports/25445-us-market-for-chronic-venous-insufficiency-treatment-2009.html

Chinese Markets for Cervical Cancer Treatment Drugs
http://www.reportsnreports.com/reports/10817-chinese-markets-for-cervical-cancer-treatment-drugs.html

About Us:

ReportsnReports  is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.
Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.

Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsnreports.com/
Blog: http://reportsnreports.wordpress.com/

# # #

ReportsnReports is comprising of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.
Our client list boasts of almost all well-known publishers of such reports across
End
ReportsnReports PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share